Does ABATACEPT Cause Interstitial lung disease? 1,118 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 1,118 reports of Interstitial lung disease have been filed in association with ABATACEPT (ORENCIA). This represents 1.0% of all adverse event reports for ABATACEPT.
1,118
Reports of Interstitial lung disease with ABATACEPT
1.0%
of all ABATACEPT reports
119
Deaths
323
Hospitalizations
How Dangerous Is Interstitial lung disease From ABATACEPT?
Of the 1,118 reports, 119 (10.6%) resulted in death, 323 (28.9%) required hospitalization, and 134 (12.0%) were considered life-threatening.
Is Interstitial lung disease Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ABATACEPT. However, 1,118 reports have been filed with the FAERS database.
What Other Side Effects Does ABATACEPT Cause?
Drug ineffective (35,212)
Rheumatoid arthritis (21,898)
Pain (19,783)
Arthralgia (18,536)
Joint swelling (18,453)
Contraindicated product administered (13,559)
Fatigue (13,087)
Drug intolerance (12,451)
Rash (12,168)
Arthropathy (11,099)
What Other Drugs Cause Interstitial lung disease?
METHOTREXATE (3,049)
RITUXIMAB (2,458)
PEMBROLIZUMAB (2,113)
PREDNISONE (1,850)
CYCLOPHOSPHAMIDE (1,725)
NIVOLUMAB (1,538)
AMIODARONE (1,421)
DOXORUBICIN (1,352)
ETANERCEPT (1,267)
ADALIMUMAB (1,250)
Which ABATACEPT Alternatives Have Lower Interstitial lung disease Risk?
ABATACEPT vs ABATACEPT SUBQ /ML
ABATACEPT vs ABCIXIMAB
ABATACEPT vs ABEMACICLIB
ABATACEPT vs ABILIFY
ABATACEPT vs ABIRATERONE